Search Results - "Kreil, S"

Visual protest discourses on aviation and climate change by Kreil, Agnes S.

“…Various solutions have been suggested for the large climate impact of aviation, some of which would have far-reaching consequences for tourism. This study…”
Get full text

Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy by HOCHHAUS, A, KREIL, S, GSCHAIDMEIER, H, DRUKER, B. J, HEHLMANN, R, CORBIN, A. S, ROSEE, P. La, MÜLLER, M. C, LAHAYE, T, HANFSTEIN, B, SCHOCH, C, CROSS, N. C. P, BERGER, U

“…Selective inhibition of the BCR-ABL tyrosine kinase by imatinib (STI571, Glivec/Gleevec) is a promising new therapeutic strategy in patients with chronic…”
Get full text

The Need for Sustainability, Equity, and International Exchange: Perspectives of Early Career Environmental Psychologists on the Future of Conferences by Köhler, Jana K., Kreil, Agnes S., Wenger, Ariane, Darmandieu, Aurore, Graves, Catherine, Haugestad, Christian A. P., Holzen, Veronique, Keller, Ellis, Lloyd, Sam, Marczak, Michalina, Međugorac, Vanja, Rosa, Claudio D.

“…At the 2019 and 2021 International Conference on Environmental Psychology, discussions were held on the future of conferences in light of the enormous…”
Get full text

Course of colonization by multidrug-resistant organisms after allogeneic hematopoietic cell transplantation by Heidenreich, D., Kreil, S., Jawhar, M., Müller, N., Nolte, F., Becker, K-P., Miethke, T., Hofmann, W.-K., Klein, Stefan A.

“…Multidrug-resistant organisms (MDRO) have been developing as an emerging problem in allogeneic hematopoietic cell transplantation (HCT). Since no data are…”
Get full text

Corrigendum to “Visual protest discourses on aviation and climate change” [Annals of Tourism Research Empirical Insights 1 (2021) 100015] by Kreil, Agnes S.

Get full text

Allogeneic hematopoietic cell transplantation without fluconazole and fluoroquinolone prophylaxis by Heidenreich, D., Kreil, S., Nolte, F., Reinwald, M., Hofmann, W.-K., Klein, S.A.

“…Fluoroquinolone (FQ) and fluconazole prophylaxis is recommended for patients undergoing allogeneic hematopoietic cell transplantation (alloHCT). However, due…”
Get full text

Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapy by HANFSTEIN, Benjamin, MÜLLER, Martin C, KREIL, Sebastian, ERNST, Thomas, SCHENK, Thomas, LORENTZ, Christian, SCHWINDEL, Uwe, LEITNER, Armin, HEHLMANN, Rudiger, HOCHHAUS, Andreas

“…Point mutations of the BCR-ABL tyrosine kinase domain are considered the predominant cause of imatinib resistance in chronic myeloid leukemia. The expansion of…”
Get full text

Analysis of genomic breakpoints in p190 and p210 BCR-ABL indicate distinct mechanisms of formation by Score, J, Calasanz, M J, Ottman, O, Pane, F, Yeh, R F, Sobrinho-Simões, M A, Kreil, S, Ward, D, Hidalgo-Curtis, C, Melo, J V, Wiemels, J, Nadel, B, Cross, N C P, Grand, F H

“…We sought to understand the genesis of the t(9;22) by characterizing genomic breakpoints in chronic myeloid leukemia (CML) and BCR–ABL -positive acute…”
Get full text

Roots of clinical resistance to STI-571 cancer therapy by Barthe, C, Cony-Makhoul, P, Melo, J V, Mahon, J R

Get full text

Molecular monitoring of response to imatinib (Glivec ) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission by Paschka, P, Müller, M C, Merx, K, Kreil, S, Schoch, C, Lahaye, T, Weisser, A, Petzold, A, König, H, Berger, U, Gschaidmeier, H, Hehlmann, R, Hochhaus, A

“…A significant proportion of chronic myeloid leukemia (CML) patients achieve a major cytogenetic remission (MCR) to imatinib therapy after failing interferon…”
Get full text

The severity of FIP1L1-PDGFRA-positive chronic eosinophilic leukaemia is associated with polymorphic variation at the IL5RA locus by Burgstaller, S, Kreil, S, Waghorn, K, Metzgeroth, G, Preudhomme, C, Zoi, K, White, H, Cilloni, D, Zoi, C, Brito-Babapulle, F, Walz, C, Reiter, A, Cross, N C P

“…We have investigated the hypothesis that constitutional genetic variation in IL-5 signalling may be associated with the development or severity of…”
Get full text

Time perception in patients with major depressive disorder during vagus nerve stimulation by Biermann, T, Kreil, S, Groemer, T W, Maihöfner, C, Richter-Schmiedinger, T, Kornhuber, J, Sperling, W

“…Affective disorders may affect patients' time perception. Several studies have described time as a function of the frontal lobe. The activating eff ects of…”
Get more information

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C by MÜLLER, M. C, GATTERMANN, N, KRAUSE, S. W, NERL, C, SAYER, H. G, OTTMANN, O. G, WALLER, C, AULITZKY, W, LE COUTRE, P, FREUND, M, MERX, K, PASCHKA, P, LAHAYE, T, KÖNIG, H, KREIL, S, BERGER, U, GSCHAIDMEIER, H, HEHLMANN, R, HOCHHAUS, A, DEININGER, M. W. N, BERNDT, A, FRUEHAUF, S, NEUHAUER, A, FISCHER, T, HOSSFELD, D. K, SCHNELLER, F

“…We sought to determine dynamics of BCR-ABL mRNA expression levels in 139 patients with chronic myelogenous leukemia (CML) in early chronic phase, randomized to…”
Get full text

Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization by MÜLLER, M. C, MERX, K, WEISSER, A, KREIL, S, LAHAYE, T, HEHLMANN, R, HOCHHAUS, A

“…The sensitivity of assays designed to monitor minimal residual disease (MRD) by RT-PCR in leukemia depend on quality and quantity of RNA derived from…”
Get full text

Improvement of CME questions from Der Nervenarzt by Gutmann, A, Degirmenci, U, Kreil, S, Kornhuber, J, Weih, M

“…Multiple choice questions play an important role in training and continuing education. Der Nervenarzt has been publishing articles for continuing medical…”
Get full text

Imatinib sensitivity as a consequence of a CSF1R-Y571D mutation and CSF1 CSF1R signaling abnormalities in the cell line GDM1 by Chase, A, Schultheis, B, Kreil, S, Baxter, J, Hidalgo-Curtis, C, Jones, A, Zhang, L, Grand, F H, Melo, J V, Cross, N C P

“…Imatinib is usually a highly effective treatment for myeloproliferative neoplasms (MPNs) associated with ABL , PDGFRA or PDGFRB gene fusions; however,…”
Get full text

The patient in the psychiatric emergency ambulance: diagnoses, reasons and comparison of layperson vs. physician viewpoints by Quandt, F, Wendel, S, Degirmenci, U, Kreil, S, Bayerlein, K, Rotter, A, Kornhuber, J, Weih, M

“…A survey in specialties other than psychiatry showed that "emergency room"-patients have factors other than the presenting disease that determine the usage of…”
Get more information

Assessment of possible drug-drug interactions in psychopharmacotherapy after hospital discharge using an interactive database by Weih, M, Bachmeier, C, Degirmenci, U, Sojer, R, Kreil, S, Thürauf, N, Prokosch, H-U, Hiemke, C, Kornhuber, J

“…Psychiatry is confronted with increasing requirements in quality management, guidelines and an increasing proportion of elderly, chronic multimorbid patients…”
Get more information

Retrospective analysis of routine-MRI and correlation with aetiology of dementia, severity and neuropsychology in a memory-clinic population by Merkle, S, Kreil, S, Suttner, G, Doelken, M, Dörfler, A, Richter-Schmidinger, T, Kornhuber, J, Weih, M

“…The contribution of potential treatable dementia aetiologies diagnosed using cerebral imaging varied considerably in previous studies and was not evaluated in…”
Get more information

Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trial by Hofheinz, R-D, Hartmann, J T, Willer, A, Oechsle, K, Hartung, G, Gnad, U, Saussele, S, Kreil, S, Bokemeyer, C, Hehlmann, R, Hochhaus, A

“…The aim of this study was to determine the dose-limiting toxicity (DLT) and establish the recommended dose for mitomycin C added every 3 weeks to the standard…”
Get full text